Zobrazeno 1 - 10
of 58
pro vyhledávání: '"K. R. Scott"'
Autor:
Le T. Duong, Gouxin Wu, Christopher T. Winkelmann, Michael A. Gentile, Pete Szczerba, Randy Crawford, K. R. Scott
Publikováno v:
Bone. 93
Odanacatib (ODN) a selective and reversible cathepsin K inhibitor, inhibits bone resorption, increases bone mass and reduces fracture risk in women with osteoporosis. A 16-month (~7-remodeling cycles) study was carried out in treatment mode to assess
Autor:
Brenda L Pennypacker, Ya Zhuo, Susan Y. Smith, K. R. Scott, T. Cusick, Rana Samadfam, Le T. Duong, Charles Chen, Maureen Pickarski
Publikováno v:
Bone. 88
The objectives here were to evaluate the effects of odanacatib (ODN) at doses exceeding the clinical exposure on biomechanical properties of lumbar vertebrae (LV), hip and central femur (CF), and compare ODN to alendronate (ALN) on bone remodeling/mo
Autor:
Le T. Duong, Maureen Pickarski, Susan Y. Smith, P. Masarachia, Donald B. Kimmel, G Wesolowski, Brenda L Pennypacker, Boyd B. Scott, Rani Samadfam, Jason E. Goetzmann, K. R. Scott
Publikováno v:
Journal of Bone and Mineral Research. 27:509-523
Odanacatib (ODN) is a selective and reversible inhibitor of cathepsin K (CatK) currently being developed as a once-weekly treatment for osteoporosis. In this study, we evaluated the effects of ODN on bone turnover, bone mineral density (BMD), and bon
Autor:
Noha N. Salama, Natalie D. Eddington, Ivan O. Edafiogho, Kethireddy V.V. Ananthalakshmi, Samuel B. Kombian, Patrice L. Jackson, K. R. Scott, Mariano S. Alexander, Tiffany L. Wilson, Clive D. Hanson
Publikováno v:
Journal of Pharmaceutical Sciences. 96:2509-2531
Enaminones, enamines of beta-dicarbonyl compounds, have been known for many years. Their early use has been relegated to serving as synthetic intermediates in organic synthesis and of late, in pharmaceutical development. Recently, the therapeutic pot
Publikováno v:
Medicinal Chemistry. 1:371-381
The enaminones represent potentially useful agents for the clinical treatment in generalized tonic-clonic seizures (Epilepsia, 1993, 34(6), 1141-1145, Biopharm. Drug Disp. 2003, 397-407). A regression analysis was performed to provide a quantitative
Publikováno v:
Journal of Combinatorial Chemistry. 6:950-954
An improved method for the synthesis of benzamides from 3-amino-2-cyclohexenones is presented. Using sodium hydride, a base-catalyzed N-benzoylation provided significantly higher yields (71-79%) for the reported compounds. This novel protocol was app
Publikováno v:
Journal of Liquid Chromatography & Related Technologies. 24:565-577
A simple high performance liquid chromatography (HPLC) method has been developed for the stability study of an anticonvulsant enaminone (E139). Using a Chiral HSA column and a mobile phase of n-octanoic acid (5 mM) and isopropyl alcohol and disodium
Autor:
Lyndia D. Sims, Jacqueline A. Moore, Kymberle R. Kolen, Ivan O. Edafiogho, Mariano S. Alexander, Gary O. Rankin, K. R. Scott, Vida A. Farrar, Ahn D. Tonnu, James P. Stables
Publikováno v:
Journal of Medicinal Chemistry. 38:4033-4043
In a continuing evaluation of the aniline-substituted enaminones, the synthesis of additional para-substituted analogs has been made in an attempt to further quantify the electronic (sigma) and lipophilic (pi) requirements for anticonvulsant activity
Autor:
John E. Fisher, Helmut Glantschnig, Brenda L Pennypacker, K. R. Scott, Ronald B. Langdon, Tara E. Cusick, B. B. Zhang, Donald B. Kimmel, J. Mu, X. Shen, Z. Li
Publikováno v:
Diabetes, obesitymetabolism. 15(10)
Antihyperglycaemic therapy on bone was evaluated in the ovariectomized (OVX), non-diabetic adult rat. Animals were treated daily for 12 weeks with various doses of sitagliptin, pioglitazone, rosiglitazone, combinations of sitagliptin with pioglitazon
Publikováno v:
Current Medicinal Chemistry. 1:159-175
Enaminones, enamines of B-dicarbonyl compounds have been known for many years. Their main therapeutic utility was as prodrugs for various amines, stabilizing these active compounds principally in basic media. Our laboratory discovered a series of ena